Back

Renal dysfunction and risk of major adverse event and suboptimal control with vitamin K antagonists in a real life cohort of anticoagulated patients with non-valvular atrial fibrillation

28 August 2016 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Anticoagulation in atrial fibrillation III Atrial fibrillation (AF) ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Carlos Pena Gil

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)

24 More presentations in this session

Presentation thumbnail
Professor D. Xavier (Bangalore, IN)
Abstract Slides
Presentation thumbnail
Doctor C. Gatti (Ravenna, IT)
Abstract Slides
Presentation thumbnail
Doctor D. Iglesias (Santiago de Compostela, ES)
Abstract Slides
Presentation thumbnail
Doctor J. Wieczorek (Katowice, PL)
Abstract Slides
Presentation thumbnail
Associate Professor A. Parwani (Berlin, DE)

Access the full session

Session thumbnail
Poster session 3 - Anticoagulation in atrial fibrillation III

The Event

Event poster

ESC Congress 2016

28 August 2016 14:00 CET
You may be interested in
thumbnail
Congress Presentation
2 September 2019
thumbnail
Congress Presentation
Meta-analysis comparing impact of age, sex and renal function on the efficacy and safety of new oral anticoagulants vs. vitamin K antagonists for the treatment of acute venous thromboembolisms
28 August 2020
thumbnail
Congress Session
Practical insights for your atrial fibrillation patients
26 August 2023
thumbnail
Congress Presentation
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources